IQVIA and Clalit Health Services Partner to Advance Research by Launching Israel’s First Prime Site | Nation/World

0

RESEARCH TRIANGLE PARK, NC–(BUSINESS WIRE)–Nov 10, 2022–

IQVIA ™ (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services for the life sciences industry, today announced a long-term collaboration with Clalit , the largest health services organization in Israel, to launch the first Prime Site in the country.

The collaboration combines IQVIA and Clalit’s capabilities in conducting clinical trials, real-world research, data and genomics. Clalit operates a network of 14 hospitals and over 1,600 primary care clinics. The health services organization provides comprehensive therapeutic coverage with significant, but not limited, expertise in oncology, rare pediatric diseases, and genomics. With this combined expertise, the collaboration will focus on the future of innovation, including precision medicine and conducting data-driven trials.

“IQVIA is delighted to launch its first main site in Israel with such an innovative and established healthcare organization as Clalit,” said Alistair Grenfell, President, Europe, Middle East, Africa and South Asia, IQVIA. “The work done through this collaboration will transform medical and pharmaceutical research for Israel and the world, improving patient outcomes.”

With IQVIA’s Connected Intelligence™ and Clalit’s mission to transform data based on electronic medical records into improved policy and better healthcare, the collaboration ensures that IQVIA can respond to pharmaceutical interest in Israel as as a destination of choice for research and innovation. The main site also ensures that IQVIA can provide an in-country solution to Israeli pharmaceutical and biotech companies.

“As the largest healthcare organization in Israel, Clalit will now leverage its Preferred Site designation to provide our patients with access to the most advanced therapies currently in development,” said Mr. Eli Cohen, Chief Executive Officer. ad interim, Clalit Health Services. “We are excited to collaborate with IQVIA and increase their ability to conduct innovative healthcare research in Israel. Through the use of data and the strategic delivery of research and care, our work together will help to better understand pharmaceutical and health developments in the real world,” he added.

About IQVIA

IQVIA (NYSE: IQV) is a leading global provider of advanced analytics, technology solutions and clinical research services for the life sciences industry. IQVIA creates intelligent connections in all aspects of healthcare through its analytics, transformative technology, big data resources and deep domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility, enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 83,000 employees, IQVIA does business in more than 100 countries.

IQVIA is a global leader in protecting patient privacy. The company uses a wide variety of technologies and privacy safeguards to protect the privacy of individuals while generating and analyzing information at a scale that helps healthcare actors identify disease patterns and to correlate with the specific treatment and therapy needed for best results. IQVIA’s knowledge and execution capabilities help biotechnology, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders harness a deeper understanding of diseases, human behavior and scientific advances, with the aim of advancing on the path to cures. To learn more, visit www.iqvia.com.

About Clalit Health Services

Clalit, the largest and leading payor-provider healthcare organization in Israel, provides integrated lifelong inpatient and outpatient medical services to more than 52% of Israel’s population. With over 1600 outpatient clinics across the country, 14 public hospitals and a wide variety of services through subsidiary companies – Clalit Smile Dental Clinics, Clalit Aesthetics, Clalit Complementary Medicine and ‘Mor’ Medical Institutes and Services. As in an innovation-driven organization, Clalit is globally recognized as a forerunner in the field of digital health and data-driven research and innovation center, with a particular focus on proactive preventive care and diseases that support a healthy lifestyle, with state-of-the-art services delivered across the country – anywhere, anytime.

For more information: www.clalit.co.il

Show source version on businesswire.com:https://www.businesswire.com/news/home/20221110005815/en/

CONTACT: Nick Childs, IQVIA Investor Relations ([email protected])

+1.973.316.3828

Trent Brown, IQVIA Media Relations ([email protected])

+1.919.780.3221

KEYWORD: UNITED STATES NORTH AMERICA ISRAEL MIDDLE EAST NORTH CAROLINA

KEYWORD INDUSTRY: RESEARCH TECHNOLOGY HOSPITALS GENETICS CLINICAL TRIALS HEALTH TECHNOLOGY BIOTECHNOLOGY SCIENCE OF HEALTH DATA MANAGEMENT

SOURCE: IQVIA

Copyright BusinessWire 2022.

PUBLISHED: 10/11/2022 11:00 AM/DISC: 10/11/2022 11:02 AM

http://www.businesswire.com/news/home/20221110005815/en

Share.

Comments are closed.